SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 114 filers reported holding SUTRO BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,724 | -47.2% | 19,517 | -29.2% | 0.00% | – |
| Q2 2023 | $128,224 | -44.7% | 27,575 | -45.0% | 0.00% | – |
| Q1 2023 | $231,753 | +404.1% | 50,163 | +781.6% | 0.00% | – |
| Q4 2022 | $45,975 | +474.7% | 5,690 | +331.7% | 0.00% | – |
| Q3 2022 | $8,000 | -42.9% | 1,318 | -52.1% | 0.00% | – |
| Q2 2022 | $14,000 | -95.5% | 2,752 | -92.8% | 0.00% | – |
| Q1 2022 | $313,000 | -59.7% | 38,109 | -27.0% | 0.00% | – |
| Q4 2021 | $777,000 | -63.6% | 52,217 | -53.7% | 0.00% | – |
| Q3 2021 | $2,132,000 | -18.2% | 112,820 | -19.5% | 0.00% | -100.0% |
| Q2 2021 | $2,606,000 | -20.3% | 140,169 | -2.5% | 0.00% | 0.0% |
| Q1 2021 | $3,271,000 | +140.2% | 143,735 | +129.1% | 0.00% | – |
| Q4 2020 | $1,362,000 | +196.7% | 62,746 | +37.3% | 0.00% | – |
| Q3 2020 | $459,000 | +92.9% | 45,687 | +48.9% | 0.00% | – |
| Q2 2020 | $238,000 | +9.2% | 30,675 | +42.9% | 0.00% | – |
| Q1 2020 | $218,000 | +2.3% | 21,462 | +10.5% | 0.00% | – |
| Q4 2019 | $213,000 | +67.7% | 19,421 | +39.4% | 0.00% | – |
| Q3 2019 | $127,000 | -2.3% | 13,935 | +21.3% | 0.00% | – |
| Q2 2019 | $130,000 | +242.1% | 11,484 | +240.7% | 0.00% | – |
| Q1 2019 | $38,000 | +26.7% | 3,371 | +2.2% | 0.00% | – |
| Q4 2018 | $30,000 | – | 3,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |